LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,187
تعداد مقالات10,822
تعداد مشاهده مقاله72,790,618
تعداد دریافت فایل اصل مقاله12,887,514
Arabkermani, Zahra, Sharifian, Roxana, Bastani, Peivand, Bashiri, Azadeh, Sheikhtaheri, Abbas. (1404). Requirements for Vitiligo Registry Design in Iran: A Qualitative Content Analysis Study. سامانه مدیریت نشریات علمی, 13(2), 220-228. doi: 10.30476/jhsss.2024.101583.1884
Zahra Arabkermani; Roxana Sharifian; Peivand Bastani; Azadeh Bashiri; Abbas Sheikhtaheri. "Requirements for Vitiligo Registry Design in Iran: A Qualitative Content Analysis Study". سامانه مدیریت نشریات علمی, 13, 2, 1404, 220-228. doi: 10.30476/jhsss.2024.101583.1884
Arabkermani, Zahra, Sharifian, Roxana, Bastani, Peivand, Bashiri, Azadeh, Sheikhtaheri, Abbas. (1404). 'Requirements for Vitiligo Registry Design in Iran: A Qualitative Content Analysis Study', سامانه مدیریت نشریات علمی, 13(2), pp. 220-228. doi: 10.30476/jhsss.2024.101583.1884
Arabkermani, Zahra, Sharifian, Roxana, Bastani, Peivand, Bashiri, Azadeh, Sheikhtaheri, Abbas. Requirements for Vitiligo Registry Design in Iran: A Qualitative Content Analysis Study. سامانه مدیریت نشریات علمی, 1404; 13(2): 220-228. doi: 10.30476/jhsss.2024.101583.1884

Requirements for Vitiligo Registry Design in Iran: A Qualitative Content Analysis Study

Journal of Health Sciences & Surveillance System
دوره 13، شماره 2، تیر 2025، صفحه 220-228    اصل مقاله (405.98 K)
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.30476/jhsss.2024.101583.1884
نویسندگان
Zahra Arabkermani1، 2؛ Roxana Sharifian2؛ Peivand Bastani2؛ Azadeh Bashiri2؛ Abbas Sheikhtaheri* 3
1Department of Paramedicine, Amol School of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran
2Department of Health Information Management, School of Health Management and Information Sciences, Health Human Resources Research Center, Clinical Education Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Health Information Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran
چکیده
Background: Vitiligo is a prevalent skin disorder that has significant biological and social consequences for the affected individuals. Therefore, appropriate measures should be taken to diagnose this disease and treat patients, and powerful information and monitoring systems, such as a registry, are required. This study aimed to identify the design requirements for vitiligo registry in Iran.
Methods: This qualitative study was conducted using a content analysis approach in 2020. In total, 9 dermatologists and health information management and medical informatics specialists working in Tehran, Shiraz, and Mashhad universities of medical sciences were interviewed. The participants were selected by a non-random purposive sampling method. The data were analyzed manually using thematic analysis approach.
Results: In this study, 7 major themes and 14 sub-themes were obtained regarding vitiligo registry design requirements. The major themes included registry objectives, structure, data sources, inclusion criteria, classification system, data quality control, and data reporting.
Conclusion: In total, 7 major themes and 14 sub-themes were identified to design the vitiligo registry. Developing a vitiligo registry based on these requirements could provide a better understanding of this disease, deliver high-quality services to patients across the country, and facilitate research on this disease.

تازه های تحقیق

Zahra Arabkermani (Google Scholar)

Abbas Sheikhtaheri (Google Scholar)

کلیدواژه‌ها
Requirements؛ Registry؛ Vitiligo؛ Iran
مراجع
  1. Seneschal J, Boniface K, D’Arino A, Picardo M. An update on Vitiligo pathogenesis. Pigment cell & melanoma research. 2021; 34(2):236-43. doi: 1111/pcmr.12949.
  2. Sandru F, Carsote M, Albu SE, Dumitrascu MC, Valea A. Vitiligo and chronic autoimmune thyroiditis. J Med Life. 2021; 14(2): 127-30. doi: 25122/jml-2019-0134. PMCID: PMCID:8169145. PMID: 34104234.
  3. Das S, Kaur S. Nano-Lipid-Carriers for the Treatment of Vitiligo: A Recent Update, Pathophysiology and Mechanism of Drug Delivery. Current molecular pharmacology. 2021; 14(3): 306-20.doi: 2174/1874467213999201109220714.
  4. Tang L, Li F, Xu F, Yan S, Zhou J, Li J, et al. Prevalence of vitiligo and associated comorbidities in adults in Shanghai, China: a community-based, cross-sectional survey. Annals of palliative medicine. 2021; 10(7):8103-11.doi: 10.21037/apm-21-1738.
  5. Chan MF, Chua TL, Goh BK, Aw CWD, Thng TGS, Lee SM. Investigating factors associated with depression of vitiligo patients in Singapore. Journal of clinical nursing. 2012; 21(11-12):1614-21. doi: 10.1111/j.1365-2702.2011.03777.x.
  6. Khaitan BK, Sindhuja T. Autoimmunity in vitiligo: Therapeutic implications and opportunities. Autoimmunity reviews. 2022; 21(1): 102932. doi: 10.1016/j.autrev.2021.102932.
  7. Mattingly R. Management of health information: functions and applications: Delmar Pub; 1997.
  8. Aghaei S, Safaee Ardekani G. Topical immunotherapy with diphenylcyclopropenone in vitiligo: a preliminary experience. Indian Journal of Dermatology, Venereology & 2008; 74(6).doi: 10.4103/0378-6323.45108.PMID: 19171989.
  9. Hallaji Z, Ghiasi M, Eisazadeh A, Rayati Damavandi M. Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy. Photodermatology, photoimmunology & photomedicine. 2012; 28(3):9-115.doi: 10.1111/j.1600-0781.2012.00648.x.
  10. Gliklich RE, Dreyer NA, Leavy MB. Registries for evaluating patient outcomes: a user’s guide. 2014.
  11. DiMarco G, Hill D, Feldman SR. Review of patient registries in dermatology. Journal of the American Academy of Dermatology. 2016; 75(4): 824-9. doi: 10.1016/j.jaad.2016.03.020.
  12. Amin M, Lee EB, Bhutani T, Wu JJ. Review of European registries for psoriasis. Journal of Dermatological Treatment. 2019; 30(3): 227-36. doi: 10.1080/09546634.2018.1506084.
  13. Shi Q, Duvic M, Osei JS, Hordinsky MK, Norris DA, Price VH, et al., editors. Health-related quality of life (HRQoL) in alopecia areata patients—A secondary analysis of the National Alopecia Areata Registry Data. Journal of Investigative Dermatology Symposium Proceedings; 2013: Elsevier. doi: 10.1038/jidsymp.2013.18.
  14. Fleckman P. The National Registry for Ichthyosis and Related Disorders Will Cease Operation after 2012. The Journal of Investigative Dermatology. 2012; 132(7): 1745.
  15. Hinojosa JA, Pandya AG, editors. The importance of patient registries in skin of color. Journal of Investigative Dermatology Symposium Proceedings; 2017: Elsevier. doi: 10.1016/j.jisp.2017.01.002.
  16. Naldi L, Chatenoud L. Registry research in dermatology. Dermatologic clinics. 2009; 27(2): 185-91. doi: 10.1016/j.det.2008.11.004.
  17. Ingelfinger JR, Drazen JM. Registry research and medical privacy. Mass Medical Soc; 2004. p.1452-3. doi: 1056/nejme048027 . PMID: 15070797.
  18. Moghadasi Cheveinli M, Z MS. The comparative study of registry system of psoriasis in Iran and selected countries and presenting a proposed model for Iran: Shiraz University of Medical Scienes, School of Management and Medical Information; 2019.
  19. Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: Striving to meet the trustworthiness criteria. International journal of qualitative methods. 2017; 16(1): 1609406917733847. doi: 10.1177/1609406917733847.
  20. Guba EG, Lincoln YS. Competing paradigms in qualitative research. Handbook of qualitative research. 1994; 2(163-194): 105.
  21. Driessen R, Boezeman J, Van de Kerkhof P, De Jong E. Three‐year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome. British Journal of Dermatology. 2009; 160(3): 670-5. doi: 10.1111/j.1365-2133.2008.09019.x.
  22. Augustin M, Spehr C, Radtke MA, Boehncke WH, Luger T, Mrowietz U, et al. German psoriasis registry PsoBest: objectives, methodology and baseline data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2014; 12(1): 48-57. doi: 10.1111/ddg.12233.
  23. Kimball A, Leonardi C, Stahle M, Gulliver W, Chevrier M, Fakharzadeh S, et al. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease‐based registry (PSOLAR). British Journal of Dermatology. 2014; 171(1): 137-47. doi: 10.1111/bjd.13013.
  24. Pillay M, Noor Hisham A, Zaki Morad M, Lim T, Jamaiyah H, Jaya Purany S. Patient registries in Malaysia and the role of the Clinical Research Centre of the Ministry of Health. Med J Malaysia. 2008; 63 (Suppl C): 1-4.
  25. Duvic M, Norris D, Christiano A, Hordinsky M, Price V, editors. Alopecia areata registry: an overview. Journal of Investigative Dermatology Symposium Proceedings; 2003: Elsevier. doi: 10.1046/j.1087-0024.2003.00814.x.
  26. Lavian J, Li SJ, Lee EY, Bordone LA, Polubriaginof FC, Christiano AM, et al. Validation of case identification for alopecia areata using International Classification of Diseases coding. International Journal of Trichology. 2020; 12(5): 234. doi: 10.4103/ijt.ijt_67_20.
  27. Hoeijmakers F, Beck N, Wouters MW, Prins HA, Steup WH. National quality registries: how to improve the quality of data? Journal of thoracic disease. 2018; 10 (Suppl 29): S. 3490. doi: 10.21037/jtd.2018.04.146. PMCID: PMC6230825 . PMID: 30510784.
آمار
تعداد مشاهده مقاله: 21
تعداد دریافت فایل اصل مقاله: 12


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب